21 studies found for:    Schilder's Disease
Show Display Options
Rank Status Study
21 Recruiting A Study of LY2228820 for Recurrent Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Drug: LY2228820;   Drug: Carboplatin;   Drug: Placebo;   Drug: Gemcitabine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-21) Next Page   
Indicates status has not been verified in more than two years